Joan M Boylan1, Heather Francois-Vaughan, Philip A Gruppuso, Jennifer A Sanders. 1. 1 Department of Pediatrics, Rhode Island Hospital and Brown University, Providence, RI. 2 Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI. 3 Department of Pathology and Laboratory Medicine, Brown University, Providence, RI.
Abstract
BACKGROUND: The limited availability of donor organs has led to a search for alternatives to liver transplantation to restore liver function and bridge patients to transplantation. We have shown that the proliferation of late gestation (embryonic day 19) fetal rat hepatocytes is mitogen-independent and that mechanisms regulating mRNA translation, cell cycle progression, and gene expression differ from those of adult rat hepatocytes. In the present study, we investigated whether E19 fetal hepatocytes can engraft and repopulate an injured adult liver. METHODS: Fetal hepatocytes were isolated using a monoclonal antibody against a hepatic surface protein, leucine amino peptidase (LAP). LAP+ and LAP- fractions were analyzed by immunofluorescence and microarray. Immunopurified E19 liver cells from DPPIV+ rats were transplanted via splenic injection into partial hepatectomized DPPIV- rats that had been pretreated with mitomycin C. RESULTS: More than a third of LAP+ fetal hepatocytes expressed ductal markers. Transcriptomic analysis revealed that these dual-expressing cells represent a population of less well-differentiated hepatocytes. Upon transplantation, LAP+ late gestation fetal hepatocytes formed hepatic, endothelial, and ductal colonies within 1 month. By 10 months, colonies derived from LAP+ cells increased so that up to 35% of the liver was repopulated by donor-derived cells. CONCLUSIONS: Late gestation fetal hepatocytes, despite being far along in the differentiation process, possess the capacity for extensive liver repopulation. This is likely related to the unexpected presence of a significant proportion of hepatocyte marker-positive cells maintaining a less well-differentiated phenotype.
BACKGROUND: The limited availability of donor organs has led to a search for alternatives to liver transplantation to restore liver function and bridge patients to transplantation. We have shown that the proliferation of late gestation (embryonic day 19) fetal rat hepatocytes is mitogen-independent and that mechanisms regulating mRNA translation, cell cycle progression, and gene expression differ from those of adult rat hepatocytes. In the present study, we investigated whether E19 fetal hepatocytes can engraft and repopulate an injured adult liver. METHODS: Fetal hepatocytes were isolated using a monoclonal antibody against a hepatic surface protein, leucine amino peptidase (LAP). LAP+ and LAP- fractions were analyzed by immunofluorescence and microarray. Immunopurified E19 liver cells from DPPIV+ rats were transplanted via splenic injection into partial hepatectomized DPPIV-rats that had been pretreated with mitomycin C. RESULTS: More than a third of LAP+ fetal hepatocytes expressed ductal markers. Transcriptomic analysis revealed that these dual-expressing cells represent a population of less well-differentiated hepatocytes. Upon transplantation, LAP+ late gestation fetal hepatocytes formed hepatic, endothelial, and ductal colonies within 1 month. By 10 months, colonies derived from LAP+ cells increased so that up to 35% of the liver was repopulated by donor-derived cells. CONCLUSIONS: Late gestation fetal hepatocytes, despite being far along in the differentiation process, possess the capacity for extensive liver repopulation. This is likely related to the unexpected presence of a significant proportion of hepatocyte marker-positive cells maintaining a less well-differentiated phenotype.
Authors: Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov Journal: Proc Natl Acad Sci U S A Date: 2005-09-30 Impact factor: 11.205
Authors: W R Kim; J R Lake; J M Smith; M A Skeans; D P Schladt; E B Edwards; A M Harper; J L Wainright; J J Snyder; A K Israni; B L Kasiske Journal: Am J Transplant Date: 2017-01 Impact factor: 8.086
Authors: George K Michalopoulos; William C Bowen; Karen Mulè; Juan Carlos Lopez-Talavera; Wendy Mars Journal: Hepatology Date: 2002-08 Impact factor: 17.425
Authors: Milankumar Prajapati; Michael A Pettiglio; Heather L Conboy; Courtney J Mercadante; Shintaro Hojyo; Toshiyuki Fukada; Thomas B Bartnikas Journal: Biometals Date: 2021-03-13 Impact factor: 3.378
Authors: Philip A Gruppuso; Joan M Boylan; Valerie Zabala; Nicola Neretti; Nebiyu A Abshiru; Jacek W Sikora; Emma H Doud; Jeannie M Camarillo; Paul M Thomas; Neil L Kelleher; Jennifer A Sanders Journal: PLoS One Date: 2018-09-07 Impact factor: 3.240
Authors: Valerie Zabala; Joan M Boylan; Paul Thevenot; Anderson Frank; Dewahar Senthoor; Varun Iyengar; Hannah Kim; Ari Cohen; Philip A Gruppuso; Jennifer A Sanders Journal: PLoS One Date: 2019-12-31 Impact factor: 3.752